About: Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $7.47 (+1.36%)
EOLS NASDAQ Evolus Inc
Evolus Inc share price
EOLS price activity
Last Price
$6.990
Change (24hr)
-0.49 USD (6.49%)
Volume
442.21K
Volume (4w avg)
-
Open
$6.64
Day Range
$6.41 - $7.27
Previous Close
$7.47
Last Trade
05 Nov, 4:08 pm GMT+0
Delayed
05 Nov, 4:08 pm GMT+0
EOLS price performance
Delayed
05 Nov, 4:08 pm GMT+0
EOLS details
EOLS Market Signals